Please provide your email address to receive an email when new articles are posted on . Higher ustekinumab trough concentration levels correlated with increased rates of endoscopic remission among ...
INCHEON, South Korea--(BUSINESS WIRE)--Today, Celltrion Healthcare announced two new data sets on the SC formulation of infliximab, Remsima ® (CT-P13) in IBD, at the European Crohn’s and Colitis ...
Dear Dr. Roach: My doctor invariably prescribes four 200 mg Advils (ibuprofen), to be taken three times every 24 hours for a few days. I suspect this will create useful peaks, but also create unwanted ...
Choice of starting dose for biopharmaceuticals in first-in-human phase I cancer clinical trials. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Week 14 trough levels predicted sustained remission vs.
Time to secondary resistance (TSR) after interruption of imatinib (IM) in advanced GIST: Updated results of the prospective French Sarcoma Group randomized phase III trial on long-term survival. This ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: My doctor invariably prescribes four 200 mg Advils ...
Q: My doctor invariably prescribes four 200 mg Advils (ibuprofen), to be taken three times every 24 hours for a few days. I suspect this will create useful peaks but also create unwanted troughs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results